Human immunity to M. tuberculosis: T cell subsets and antigen processing

Tuberculosis
W H BoomMarta Torres

Abstract

A hallmark of M. tuberculosis infection is the ability of most (90-95%) healthy adults to control infection through acquired immunity, in which antigen specific T cells and macrophages arrest growth of M. tuberculosis bacilli and maintain control over persistent bacilli. In addition to CD4+ T cells, other T cell subsets such as, gammadelta, CD8+ and CD1-restricted T cells have roles in the immune response to M. tuberculosis. A diverse T cell response allows the host to recognize a wider range of mycobacterial antigens presented by different families of antigen-presenting molecules, and thus greater ability to detect the pathogen. Macrophages are key antigen presenting cells for T cells, and M. tuberculosis survives and persists in this central immune cell. This is likely an important factor in generating this T cell diversity. Furthermore, the slow growth and chronic nature of M. tuberculosis infection results in prolonged exposure to antigens, and hence further T cell sensitization. The effector mechanisms used by T cells to control M. tuberculosis are poorly understood. To survive in macrophages, M. tuberculosis has evolved mechanisms to block immune responses. These include modulation of phagosomes, neutralization of macroph...Continue Reading

References

Sep 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P C Hopewell
Mar 1, 1992·The Journal of Infectious Diseases·P F BarnesR L Modlin
Sep 1, 1991·The Journal of Experimental Medicine·J B HaanenH Spits
Jun 6, 1991·The New England Journal of Medicine·P F BarnesD E Snider
Dec 1, 1993·The Journal of Experimental Medicine·J L FlynnB R Bloom
Dec 1, 1993·The Journal of Experimental Medicine·A M CooperI M Orme
Dec 26, 1996·The New England Journal of Medicine·E JouanguyJ L Casanova
Feb 1, 1997·Current Opinion in Immunology
Nov 18, 1997·Cell·R Medzhitov, C A Janeway
Feb 21, 1998·Proceedings of the National Academy of Sciences of the United States of America·A LalvaniA V Hill
Mar 9, 1999·The Journal of Infectious Diseases·C S HirschJ J Ellner
Mar 4, 2000·Veterinary Immunology and Immunopathology·J HopkinsS M Rhind
Jul 19, 2000·Infection and Immunity·H Sicard, J J Fournie
Oct 13, 2001·The New England Journal of Medicine·J KeaneM M Braun

❮ Previous
Next ❯

Citations

Oct 30, 2009·Archivum Immunologiae Et Therapiae Experimentalis·Giovanni FerraraLucio Casali
Apr 16, 2010·Journal of Clinical Immunology·Jing JiangXiaoxing Cheng
Jun 24, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gabriel ChamieDiane V Havlir
Jun 25, 2008·International Immunology·Verena VoelterVictor Appay
Jun 14, 2013·Clinical and Vaccine Immunology : CVI·Resmi RavindranImran H Khan
Nov 1, 2005·Mediators of Inflammation·Figen DeveciM Hamdi Muz
Aug 3, 2006·Mediators of Inflammation·Figen DeveciFulya Ilhan
Apr 9, 2008·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Mikako HiuraYuji Hinoda
Oct 8, 2005·American Journal of Respiratory and Critical Care Medicine·Claudia CarranzaStephan K Schwander
Feb 28, 2009·American Journal of Respiratory and Critical Care Medicine·Prabhat K SharmaDipendra K Mitra
Oct 27, 2005·American Journal of Respiratory and Critical Care Medicine·UNKNOWN American Thoracic SocietyUNKNOWN Infectious Diseases Society of America
Oct 5, 2010·American Journal of Respiratory Cell and Molecular Biology·Seónadh O'LearyJoseph Keane
Aug 3, 2007·The Journal of Clinical Investigation·W Henry Boom
Aug 4, 2011·European Journal of Medical Research·Abdulkarim Al-AskaN A Al Anazi
Apr 22, 2009·PLoS Pathogens·Crystal Y ChenZheng W Chen
Oct 16, 2010·Journal of Zoo and Wildlife Medicine : Official Publication of the American Association of Zoo Veterinarians·Jennifer A LandolfiKaren A Terio
Apr 12, 2012·The American Journal of Tropical Medicine and Hygiene·C Scott MahanW Henry Boom
May 14, 2014·Proceedings of the National Academy of Sciences of the United States of America·Alexandria DavidMegan MacLeod
May 24, 2014·Molecular Immunology·Md Kawsar KhanZeba I Seraj
Jul 9, 2009·Journal of Biomedicine & Biotechnology·Kun-Nan TsaiChung-Ming Chen
Aug 5, 2011·Immunobiology·Antima GuptaSanjib Bhakta
Oct 8, 2008·The Journal of Infection·Patricia Méndez-Samperio
Dec 7, 2007·Scandinavian Journal of Immunology·J-S LeeE-K Jo
Feb 28, 2006·Medical Hypotheses·Carlos Pérez-Guzmán, Mario H Vargas
Mar 20, 2010·Microbiology·Seth P HarrisStephen A Hines
Apr 8, 2015·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Eun Youn RohMyoung Hee Park
Aug 25, 2005·Expert Review of Vaccines·Marien I de JongeStewart T Cole

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
Joo Wan SeoMin Ki Lee
Current Infectious Disease Reports
M I Buitrago, G Friedland
Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics
N SaitoH Sayama
© 2022 Meta ULC. All rights reserved